598 related articles for article (PubMed ID: 10989749)
1. [Activation of the renin-angiotensin system and blood pressure variability in rats].
Blanc J; Lambert G; Elghozi JL
Arch Mal Coeur Vaiss; 2000 Aug; 93(8):1019-22. PubMed ID: 10989749
[TBL] [Abstract][Full Text] [Related]
2. [Contribution of the renin-angiotensin system to blood pressure variability in hyperthyroid rats].
Basset A; Blanc J; Elghozi JL
Arch Mal Coeur Vaiss; 2000 Aug; 93(8):905-10. PubMed ID: 10989728
[TBL] [Abstract][Full Text] [Related]
3. [Contribution of the renin-angiotensin system to the variability of blood pressure in hypertensive rat after blockade of nitric oxide synthesis].
Gouédard O; Gaudet E; Blanc J; Ponchon P; Elghozi JL
Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1013-7. PubMed ID: 8949370
[TBL] [Abstract][Full Text] [Related]
4. Endogenous renin and related short-term blood pressure variability in the conscious rat.
Blanc J; Lambert G; Elghozi JL
Eur J Pharmacol; 2000 Apr; 394(2-3):311-20. PubMed ID: 10771297
[TBL] [Abstract][Full Text] [Related]
5. [Hormonal contribution to short-term variability of blood pressure in a renovascular hypertension model].
Ponchon P; Elghozi JL
Arch Mal Coeur Vaiss; 1995 Aug; 88(8):1203-7. PubMed ID: 8572874
[TBL] [Abstract][Full Text] [Related]
6. Effect of angiotensin II on pulse wave velocity in humans is mediated through angiotensin II type 1 (AT(1)) receptors.
Rehman A; Rahman AR; Rasool AH
J Hum Hypertens; 2002 Apr; 16(4):261-6. PubMed ID: 11967720
[TBL] [Abstract][Full Text] [Related]
7. Contribution of the renin-angiotensin system to short-term blood pressure variability during blockade of nitric oxide synthesis in the rat.
Gouédard O; Blanc J; Gaudet E; Ponchon P; Elghozi JL
Br J Pharmacol; 1996 Nov; 119(6):1085-92. PubMed ID: 8937709
[TBL] [Abstract][Full Text] [Related]
8. Dissociation of blood pressure and sympathetic activation of renin release in sinoaortic-denervated rats.
Krieger MH; Moreira ED; Oliveira EM; Oliveira VL; Krieger EM; Krieger JE
Clin Exp Pharmacol Physiol; 2006; 33(5-6):471-6. PubMed ID: 16700880
[TBL] [Abstract][Full Text] [Related]
9. Comparison of angiotensin II-induced blood pressure and structural changes in Fischer 344 and Wistar Kyoto rats.
Blanc J; Lacolley P; Laurent S; Elghozi JL
Clin Exp Pharmacol Physiol; 2004 Jul; 31(7):466-73. PubMed ID: 15236636
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist. 1st communication: antihypertensive effects of valsartan in hypertensive models.
Yamamoto S; Hayashi N; Kometani M; Nakao K; Inukai T
Arzneimittelforschung; 1997 May; 47(5):604-12. PubMed ID: 9205773
[TBL] [Abstract][Full Text] [Related]
11. [Effects of angiotensin II on inflammation mediators in healthy subjects].
Lottermoser K; Ulrich-Merzenich G; Vetter H; Düsing R
Dtsch Med Wochenschr; 2003 Nov; 128(47):2470-5. PubMed ID: 14628252
[TBL] [Abstract][Full Text] [Related]
12. An effect of extrarenal beta adrenergic stimulation on the release of renin.
Reid IA; Schrier RW; Earley LE
J Clin Invest; 1972 Jul; 51(7):1861-9. PubMed ID: 4402350
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist. 3rd communication: hemodynamic effects of valsartan in rats and dogs.
Hayashi N; Yamamoto S; Kometani M; Nakao K
Arzneimittelforschung; 1997 May; 47(5):620-5. PubMed ID: 9205775
[TBL] [Abstract][Full Text] [Related]
14. Time course of losartan blockade of angiotensin II hypertension versus blockade of angiotensin II fast pressor effects.
Gorbea-Oppliger VJ; Melaragno MG; Potter GS; Petit RL; Fink GD
J Pharmacol Exp Ther; 1994 Nov; 271(2):804-10. PubMed ID: 7965799
[TBL] [Abstract][Full Text] [Related]
15. Beta adrenoceptor blockade in rabbit inhibits the renin-releasing effect of AT1 receptor antagonist losartan.
Hajj-Ali AF; Wong PC
J Pharmacol Exp Ther; 1993 Dec; 267(3):1423-7. PubMed ID: 7903389
[TBL] [Abstract][Full Text] [Related]
16. Renin-angiotensin-aldosterone system, RR interval, and blood pressure variability during postural changes in borderline arterial hypertension.
Duprez DA; De Sutter JH; De Buyzere ML; Rietzschel ER; Rimbaut S; Kaufman JM; Van Hoecke MJ; Clement DL
Am J Hypertens; 1995 Jul; 8(7):683-8. PubMed ID: 7546493
[TBL] [Abstract][Full Text] [Related]
17. Endothelin-1 receptor blockade induces upregulation of renin-angiotensin-aldosterone system expression in terms of blood pressure regulation.
Bo Yang ; Chen YD; Li TD; Feng QZ
J Renin Angiotensin Aldosterone Syst; 2010 Jun; 11(2):119-23. PubMed ID: 20093323
[TBL] [Abstract][Full Text] [Related]
18. Renin-angiotensin blockade improves renal cGMP production via non-AT(2)-receptor mediated mechanisms in hypertension-induced by chronic NOS inhibition in rat.
Uhlenius N; Vuolteenaho O; Tikkanen I
J Renin Angiotensin Aldosterone Syst; 2001 Dec; 2(4):233-9. PubMed ID: 11881129
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II increases tissue-specific inhibitor of metalloproteinase-2 expression in rat aortic smooth muscle cells in vivo: evidence of a pressure-independent effect.
Castoldi G; di Gioia CR; Travaglini C; Busca G; Redaelli S; Bombardi C; Stella A
Clin Exp Pharmacol Physiol; 2007 Mar; 34(3):205-9. PubMed ID: 17250640
[TBL] [Abstract][Full Text] [Related]
20. Effect of angiotensin II infusion with and without angiotensin II type 1 receptor blockade on nitric oxide metabolism and endothelin in human beings: a placebo-controlled study in healthy volunteers.
Gossmann J; Burkhardt R; Harder S; Lenz T; Sedlmeyer A; Klinkhardt U; Haak T; Geiger H; Scheuermann EH
Clin Pharmacol Ther; 2000 Nov; 68(5):501-9. PubMed ID: 11103753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
